但是需要进一步的研究来确定吸入性皮质类固醇治疗哮喘的最佳剂量。
However, further studies are needed to determine the optimal dosing regimen for inhaled corticosteroid therapy for asthma.
研究中的患者年龄在18岁以上，并在2006年期间接受吸入性皮质类固醇制剂治疗。
Patients in the study were older than 18 years and had been given a prescription for an inhaled corticosteroid at some point during 2006.
从急诊出院以后，接受吸入性皮质类固醇治疗与随后去急诊复诊的发生率明显降低有关。
Inhaled corticosteroid therapy after Ed discharge is associated with a significant reduction in the risk of subsequent Ed visits.
应用推荐